Evidence map›Paper›PMID 18570702›Full record

ArticleThe international journal of neuropsychopharmacology2008

Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.

Abesh K Bhattacharjee, Lisa Chang, Mei Chen, Laura White, Jane M Bell, Richard P Bazinet, Stanley I Rapoport

Open access · hybridAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2012
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Na+,K+-ATPase activity in an animal model of mania.Journal of neural transmission (Vienna, Austria : 1996) · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Abesh K BhattacharjeeBrain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. abeshb@mail.nih.gov
Lisa Chang
Mei Chen
Laura White
Jane M Bell
Richard P Bazinet
Stanley I Rapoport
National Institute on Aging · USInstitute on Aging · USNational Institutes of Health · US

Funding

Imaging Brain Signal Transduction via Arachidonic and Docosahexaenoic AcidsZIAAG000134 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 2009 to 2015
$3.3M
THE NERVOUS SYSTEM IN RELATION TO FUNCTION, AGING, AND DISEASEZ01AG000134 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 1985 to 2008
$1.2M
Intramural NIH HHS NIH0011382695
6 · The paper itself

Abstract

Acute d-amphetamine (d-Amph) administration to rats leads to the release of arachidonic acid (AA, 20:4n-6) as a second messenger following indirect agonism at dopamine D2-like receptors in the brain. We hypothesized that chronically administered d-Amph in rats also would alter brain AA metabolism and signalling. To test this, adult male rats were injected i.p. daily for 2 wk with saline or 2.5 mg/kg d-Amph. After a 1-d washout, the unanaesthetized rats were injected acutely with i.v. saline, 1 mg/kg quinpirole (a D2-like receptor agonist) or 5.0 mg/kg SKF-38393 (a D1-like receptor agonist), followed by i.v. [1-14C]AA. The AA incorporation coefficient k* (brain radioactivity/integrated plasma radioactivity), a marker of AA signalling and metabolism, was quantified using autoradiography in each of 62 brain regions. Compared with chronic saline, chronic d-Amph widely decreased baseline values of k* in brain regions having D2-like receptors. On the other hand, chronic amphetamine did not alter the k* responses to quinpirole seen in chronic saline-treated rats. SKF-38393 had minimal effects on k* in both chronic saline-treated and amphetamine-treated rats, consistent with D1-like receptors not being coupled to AA signalling. The ability of chronic d-Amph after 1-d washout to down-regulate baseline values of k* probably reflects neuroplastic changes in brain AA signalling, and may correspond to depressive behaviours noted following withdrawal from chronic amphetamine in humans and in rats.

Indexed as

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineAnimalsArachidonic AcidAutoradiographyBiomarkersBrain ChemistryCentral Nervous System StimulantsDepression, ChemicalDextroamphetamineDopamine AgonistsFatty Acids, NonesterifiedHalf-LifeImage Processing, Computer-AssistedInjections, IntraperitonealMaleQuinpirole2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineArachidonic AcidBiomarkersCentral Nervous System StimulantsDextroamphetamineDopamine AgonistsFatty Acids, NonesterifiedQuinpiroleReceptors, Dopamine D2Receptors, Phospholipase A2

Identifiers

PMID18570702
PMCPMC2676692
OpenAlexW2113477511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.